| Acute Promyelocytic Leukemia studied in …STUDIED_INderived89 of 89show fewer |
|---|
| → studied in | NCT07504458Phase 3 · recruiting Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02938858completed French Registry of First-line Treatment of Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03253848NA · active not recruiting Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07597941Phase 2/Phase 3 · not yet recruiting Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409161Phase 2 · recruiting Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390635Phase 1 · recruiting PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503730Phase 3 · recruiting Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339740Phase 3 · active not recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296445Phase 3 · not yet recruiting A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882031Phase 1 · completed Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07203885NA · completed AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187505NA · active not recruiting Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04687176Phase 2 · recruiting Frontline Oral Arsenic Trioxide for APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982274Phase 2 · recruiting Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05881265Phase 2 · recruiting Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544109Phase 2/Phase 3 · enrolling by invitation Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832320NA · unknown Optimum Induction Therapy of Low-risk APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793919Phase 2 · recruiting Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192619unknown National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996030Phase 1 · suspended A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897490recruiting RWE of 1st Line Treatment With ATO/ATRA for Adult APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003861active not recruiting Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497310Phase 1/Phase 2 · unknown Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472107completed Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03624270Phase 2 · unknown Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251754unknown The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253070Phase 2 · completed Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005277completed Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200978Phase 4 · completed A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03751917unknown Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404949Phase 2 · completed Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899169Phase 3 · unknown Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096496unknown Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445080Phase 1/Phase 2 · completed Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064570Phase 2 · unknown AIDA 2000 Guidelines · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562818completed Results From a Mexican Acute Promyelocytic Leukemia. · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175587Phase 3 · unknown Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01987297Phase 4 · unknown Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00413166Phase 2 · completed All-trans Retinoic Acid, and Arsenic +/- Idarubicin · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02086773Phase 1 · completed Red Cell Transfusion Goals in Patients With Acute Leukemias · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02991066unknown Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602225Phase 1/Phase 2 · completed Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852709Phase 1 · terminated Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01902329Phase 1 · completed A Safety Study of SGN-CD33A in AML Patients · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226303Phase 3 · unknown Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185523terminated Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00670150Phase 2 · withdrawn New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588809Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146223completed Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00907582Phase 2 · terminated ASCT for Relapsed APL After Molecular Remission · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408278Phase 4 · completed Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504764Phase 4 · completed Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01910623completed Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217412Phase 1 · completed Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00985530Phase 1 · terminated Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331513Phase 1 · completed Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950611Phase 2 · unknown Proteasome Inhibition in Acute Promyelocytic Leukemia · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003934Phase 3 · completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077467Phase 1 · completed Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01463410terminated Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520208Phase 2 · completed Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005064Phase 1 · completed PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006213Phase 1 · completed BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042796Phase 1 · terminated Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00675870Phase 2 · unknown Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00465933Phase 4 · completed Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00196768Phase 4 · unknown Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic · condition mapped CURATED_BROADER · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00517712Phase 2/Phase 3 · unknown Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 89 trials mapped (16 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |